Singapore, July 24 -- Bora Health, subsidiary of SunWay Biotech which focuses on pharmaceutical distribution and sales in Taiwan, has entered into a strategic collaboration with global pharmaceutical leader Dr. Reddy's Laboratories. The partnership grants Bora Health the distribution rights in Taiwan of 4 products in the infection, central nervous system therapeutic areas and rare diseases.

This collaboration not only enhances hospital-facing portfolio of Bora Health but also aligns with Bora Group's long-term strategy to expand its footprint in rare diseases and specialty pharma, furthering its mission to close critical gaps in Taiwan's healthcare landscape.

Bobby Sheng, Chairman of SunWay Biotech, stated, "After careful evaluation on ...